AI assistant
TherapeuticsMD, Inc. — Director's Dealing 2025
Feb 21, 2025
35134_dirs_2025-02-20_45c6ab88-0982-498b-ac90-1c96afe33269.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2025-02-18
Reporting Person: Walker Marlan D (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-18 | Common Stock | M | 3467 | — | Acquired | 66032 | Direct |
| 2025-02-18 | Common Stock | M | 2311 | — | Acquired | 68343 | Direct |
| 2025-02-18 | Common Stock | M | 770 | — | Acquired | 69113 | Direct |
| 2025-02-18 | Common Stock | M | 1733 | — | Acquired | 70846 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-18 | Performance Stock Units | $0 | M | 3467 | Disposed | Common Stock (3467) | Direct | |
| 2025-02-18 | Restricted Stock Units | $0 | M | 2311 | Disposed | Common Stock (2311) | Direct | |
| 2025-02-18 | Restricted Stock Units | $0 | M | 770 | Disposed | Common Stock (770) | Direct | |
| 2025-02-18 | Restricted Stock Units | $0 | M | 1733 | Disposed | Common Stock (1733) | Direct |
Footnotes
F1: Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 3,467 shares of common stock of the issuer in settlement of PSUs.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 2,311 shares of common stock of the issuer in settlement of RSUs, which vested on July 1, 2024.
F3: Each RSU represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 770 shares of common stock of the issuer in settlement of RSUs, which vested on September 29, 2024.
F4: Each RSU represents a contingent right to receive one share of common stock of the issuer. The RSUs vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025. On February 18, 2025, the reporting person received 1,733 shares of common stock of the issuer in settlement of RSUs, which vested on March 23, 2024.